AppGenex Diagnostics, Inc.
AppGenex Diagnostics develops multiplexed diagnostic products for the detection of diseases caused by infectious pathogens.
AppGenex Diagnostics, Inc. develops and provides multiplexed products for diagnosis of infectious disease. The Company’s strategic focus is on unmet diagnostic need of human diseases, such as tuberculosis (TB), affecting the developing world. Our main product is a TB Detection Panel intended as a first-line test for use in clinics with high TB patient volumes. The panel is slated to be launched in India in 2020.